IREN
IREN Limited
There isn't enough reported data to score IREN yet.
MCBS
MetroCity Bankshares, Inc.
MCBS's fundamentals are mixed, but it looks expensive: trading at 12x earnings, in line with its usual 11x. Analysts expect earnings to hold roughly steady.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
MCBS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MCBS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCBS.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
MCBS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $24.63 | -32% |
| Fair | 11x | $33.20 | -8.4% |
| Current | 12x | $36.26 | — |
| Forward | 12x | $36.26 | — |
| Expensive | 13x | $38.33 | +5.7% |
Historical ranges are pointers, not guarantees.
MCBS's PE is in its expensive range at 11.8x. On analysts' estimates for next year's earnings, today's price would be 11.6x, in its fair range.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MCBS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect MCBS's earnings, revenue and profitability to hold roughly steady.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
MCBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.13 | +2.3% |
| Q3 2026 | $3.06 | +18% |
| Q2 2026 | $2.89 | +12% |
| Q1 2026 | $2.78 | +7.8% |
| Q4 2025 | $2.64 | +4.8% |
| Q3 2025 | $2.59 | +12% |
| Q2 2025 | $2.57 | +21% |
| Q1 2025 | $2.58 | +31% |
| Q4 2024 | $2.52 | +25% |
MCBS has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
MCBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $47.9M | +26% |
| Q2 2026 | $49.8M | +31% |
| Q1 2026 | $50.8M | +41% |
| Q4 2025 | $43.7M | +24% |
| Q3 2025 | $38M | +2.9% |
| Q2 2025 | $37.9M | +4.5% |
| Q1 2025 | $36M | +10% |
| Q4 2024 | $35.4M | +15% |
MCBS's revenue has grown year over year for 11 quarters in a row: $48M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | -4.4 points |
| Q2 2026 | 62% | -0.9 points |
| Q1 2026 | 59% | -1.9 points |
| Q4 2025 | 53% | -6.1 points |
| Q3 2025 | 63% | +1.4 points |
| Q2 2025 | 62% | -2 points |
| Q1 2025 | 61% | -1.3 points |
| Q4 2024 | 59% | +6.3 points |
MCBS has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
MCBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.6M | -203% |
| Q2 2026 | $24.9M | +74% |
| Q1 2026 | $45.8M | +287% |
| Q4 2025 | -$5.4M | -128% |
| Q3 2025 | $16.2M | +$28M |
| Q2 2025 | $14.3M | -25% |
| Q1 2025 | $11.8M | -67% |
| Q4 2024 | $18.9M | +$28.1M |
MCBS has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over MCBS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MCBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +88K shares |
| 1 year | +12% | +3.2M shares |
| 3 years | +13% | +3.4M shares |
| 5 years | +13% | +3.3M shares |
| Available history | +17% | +4.3M shares |
MCBS has 29M diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $4.4M |
| Q4 2025 | $2.7M |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | $706,000 |
MCBS spent $7M buying back its own shares over the past year.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
MCBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 2.1x | Moderate |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.4x | Healthy |
MCBS's net debt is less than a year of its operating earnings (EBITDA), down from 2.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MCBS.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
MCBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.8 | Neutral |
| Stochastic | 72.1 | Neutral |
MCBS's weekly RSI is 62 (neutral) and its Stochastic is 72 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
MCBS PE vs Financial Services Sector
| Metric | MCBS | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9% below |
| PE % | 69 | 63 | 6 pts above |
MCBS is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
MCBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.4 | 2.3% above |
| 20 week MA | $35.6 | 1.8% above |
| 50 week MA | $32.3 | 12% above |
| 100 week MA | $30.4 | 19% above |
| 200 week MA | $26.9 | 35% above |
MCBS has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
MCBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.5 | $14.3 | -18% |
| 2021 | $14.3 | $27.6 | +93% |
| 2022 | $27.6 | $21.6 | -22% |
| 2023 | $21.6 | $24.0 | +11% |
| 2024 | $24.0 | $32.0 | +33% |
| 2025 | $32.0 | $26.8 | -16% |
| 2026 YTD | $26.8 | $36.3 | +35% |
MCBS has the edge over IREN on returns for 2026, with the stronger performance.